Related Experiment Video
Updated: Mar 25, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Transcriptional signature induced by a metastasis-promoting c-Src mutant in a human breast cell line
Felix Broecker1,2, Christopher Hardt1, Ralf Herwig1
1Max Planck Institute for Molecular Genetics, Berlin, Germany.
Unlabelled:
Deletions at the C-terminus of the proto-oncogene protein c-Src kinase are found in the viral oncogene protein v-Src as well as in some advanced human colon cancers. They are associated with increased kinase activity and cellular invasiveness. Here, we analyzed the mRNA expression signature of a constitutively active C-terminal mutant of c-Src, c-Src(mt), in comparison with its wild-type protein, c-Src(wt), in the human non-transformed breast epithelial cell line MCF-10A. We demonstrated previously that the mutant altered migratory and metastatic properties. Genome-wide transcriptome analysis revealed that c-Src(mt) de-regulated the expression levels of approximately 430 mRNAs whose gene products are mainly involved in the cellular processes of migration and adhesion, apoptosis and protein synthesis. 82.9% of these genes have previously been linked to cellular migration, while the others play roles in RNA transport and splicing processes, for instance. Consistent with the transcriptome data, cells expressing c-Src(mt), but not those expressing c-Src(wt), showed the capacity to metastasize into the lungs of mice in vivo. The mRNA expression profile of c-Src(mt)-expressing cells shows significant overlap with that of various primary human tumor samples, possibly reflecting elevated Src activity in some cancerous cells. Expression of c-Src(mt) led to elevated migratory potential. We used this model system to analyze the transcriptional changes associated with an invasive cellular phenotype. These genes and pathways de-regulated by c-Src(mt) may provide suitable biomarkers or targets of therapeutic approaches for metastatic cells.
Database:
This project was submitted to the National Center for Biotechnology Information BioProject under ID PRJNA288540. The Illumina RNA-Seq reads are available in the National Center for Biotechnology Information Sequence Read Archive under study ID SRP060008 with accession numbers SRS977414 for MCF-10A cells, SRS977717 for mock cells, SRS978053 for c-Src(wt) cells and SRS978046 for c-Src(mt) cells.
Insights
Constitutively active c-Src kinase mutants promote cell migration and metastasis. This study identifies key genes and pathways altered by these mutants, offering potential therapeutic targets for cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Deletions in the C-terminus of c-Src kinase are linked to increased activity and invasiveness in viral oncogenes and some human cancers.
- Constitutively active c-Src mutants (c-Src(mt)) are known to alter cell migration and metastasis.
Purpose of the Study:
- To analyze the mRNA expression signature of a constitutively active C-terminal mutant of c-Src (c-Src(mt)) in MCF-10A cells.
- To identify transcriptional changes associated with an invasive cellular phenotype induced by c-Src(mt).
Main Methods:
- Genome-wide transcriptome analysis (RNA-Seq) of MCF-10A cells expressing c-Src(mt) versus wild-type c-Src (c-Src(wt)).
- In vivo metastasis assay in mice to assess the metastatic capacity of cells expressing c-Src(mt).
Main Results:
- c-Src(mt) de-regulated approximately 430 mRNAs involved in migration, adhesion, apoptosis, and protein synthesis.
- 82.9% of the de-regulated genes were previously linked to cellular migration.
- Cells expressing c-Src(mt) demonstrated metastatic capacity in vivo, unlike those with c-Src(wt).
- The mRNA expression profile of c-Src(mt)-expressing cells showed overlap with primary human tumor samples.
Conclusions:
- c-Src(mt) expression elevates migratory potential and drives an invasive cellular phenotype.
- The identified genes and pathways de-regulated by c-Src(mt) represent potential biomarkers or therapeutic targets for metastatic cancers.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

